That's right. One option is to look at what's been done in other countries. Have Health Canada negotiate with the drug companies to encourage them to do trials in children. I believe in the U.S.—it's been a while since I've studied their law—that for pediatric use a company will get a certain period of market exclusivity if they conduct the research for that use in children. So there are incentives available.
On April 29th, 2008. See this statement in context.